Kainos Medicine, Inc. (KOSDAQ: 284620)
South Korea
· Delayed Price · Currency is KRW 1,853.00
-86.00 (-4.44%)
Jan 22, 2025, 3:00 PM KST
Kainos Medicine Market Cap
Kainos Medicine has a market cap or net worth of 52.22 billion as of January 22, 2025. Its market cap has decreased by -55.84% in one year.
Market Cap
52.22B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
299.90
Stock Price
1,853.00
Market Cap Chart
Since June 9, 2020, Kainos Medicine's market cap has decreased from 434.22B to 52.22B, a decrease of -87.97%. That is a compound annual growth rate of -36.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 52.22B | -41.55% |
| Dec 30, 2024 | 89.33B | -25.94% |
| Dec 28, 2023 | 120.62B | 5.37% |
| Dec 29, 2022 | 114.48B | -59.11% |
| Dec 30, 2021 | 279.94B | -40.72% |
| Dec 30, 2020 | 472.24B | 8.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 355.59T |
| SK hynix | 150.21T |
| LG Energy Solution | 82.95T |
| Samsung Biologics Co.,Ltd. | 71.25T |
| Hyundai Motor Company | 45.49T |
| Kia Corporation | 39.35T |
| Celltrion | 38.12T |
| KB Financial Group | 33.29T |